Physician profile
Gregory Dyer
NPI 1043665250
$1,291.35
in general payments reported to CMS, 2019-2025
7 companies · $434 in 2025
The $434 reported for 2025 was more than what 78% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.99 · 2020: $194 · 2022: $77.15 · 2023: $72.23 · 2024: $501 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $516 · Gift: $301 · Travel and Lodging: $115 · Consulting Fee: $75.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.39 |
| Gift | $300.74 |
| Travel and Lodging | $114.83 |
| Consulting Fee | $75.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $763.47 | 2020-2025 | Invisalign |
| Ultradent Products INC | $290.49 | 2025 | Opalescence |
| Ormco Corporation | $95.13 | 2019-2023 | Damon, Spark |
| Envista Holdings Corporation | $70.54 | 2024-2025 | Spark |
| Nobel Biocare USA | $36.11 | 2023 | Nobelactive |
| Dentsply Sirona INC | $19.61 | 2024 | Suresmile |
| American Orthodontics Corporation | $16.00 | 2024 | Empower-Metal, Radiance, Empower-Ceramic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Dyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.